Asthma Treatments
Find Asthma Treatments
Medications for Asthma
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Asthma.
Found 23 Approved Drugs for Asthma
Omalizumab
Brand Names
Xolair, Xolair PFS
Omalizumab
Brand Names
Xolair, Xolair PFS
Form: Injection
Method of administration: Subcutaneous
FDA approval date: June 20, 2003
Classification: Anti-IgE
XOLAIR is an anti-IgE antibody indicated for: Moderate to severe persistent asthma in adults and pediatric patients 6 years of age and older with a positive skin test or in vitro reactivity to a perennial aeroallergen and symptoms that are inadequately controlled with inhaled corticosteroids.
Salmeterol
Brand Names
Advair Diskus, Advair HFA, AirDuo RespiClick, Salmeterol Diskus, Salmeterol HFA, SEREVENT Diskus, Wixela Inhub
Salmeterol
Brand Names
Advair Diskus, Advair HFA, AirDuo RespiClick, Salmeterol Diskus, Salmeterol HFA, SEREVENT Diskus, Wixela Inhub
Form: Aerosol, Powder
Method of administration: Respiratory (inhalation), Oral
FDA approval date: November 25, 1997
Classification: Corticosteroid
ADVAIR DISKUS is a combination product containing a corticosteroid and a long-acting beta 2 -adrenergic agonist (LABA) indicated for: Twice-daily treatment of asthma in patients aged 4 years and older.
Nucala
Generic Name
Mepolizumab
Nucala
Generic Name
Mepolizumab
Form: Injection
Method of administration: Subcutaneous
FDA approval date: November 04, 2015
Classification: Interleukin-5 Antagonist
NUCALA is an interleukin-5 (IL-5) antagonist monoclonal antibody (IgG1 kappa) indicated for: Add-on maintenance treatment of adult and pediatric patients aged 6 years and older with severe asthma and with an eosinophilic phenotype.
Formoterol
Brand Names
Duaklir Pressair, Perforomist
Formoterol
Brand Names
Duaklir Pressair, Perforomist
Form: Powder, Solution
Method of administration: Respiratory (inhalation)
FDA approval date: October 01, 2007
Classification: beta2-Adrenergic Agonist
DUAKLIR PRESSAIR is a combination of aclidinium bromide (an anticholinergic) and formoterol fumarate (a LABA) indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Limitations of Use: DUAKLIR PRESSAIR is not indicated for the relief of acute bronchospasm or for the treatment of asthma [see Warnings and Precautions.
Beclomethasone Dipropionate
Brand Names
QNASL, Qvar Redihaler
Beclomethasone Dipropionate
Brand Names
QNASL, Qvar Redihaler
Form: Aerosol
Method of administration: Respiratory (inhalation), Nasal
FDA approval date: November 01, 2017
Classification: Corticosteroid
QNASL Nasal Aerosol is a corticosteroid indicated for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis in patients 4 years of age and older.
Showing 1-5 of 23
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances